Vitalis, LLC

Vitalis is a privately-held specialty pharmaceutical company leveraging its proprietary VTS-Aspirin platform to overcome the limitations of existing drugs and enhance patient experience across a variety of therapeutic areas. We are initially targeting three highly promising therapeutic areas: multiple sclerosis; post-op pain (non-opioid); dyslipidemia. Our goal is to develop patient-centric therapies that improve disease treatment with fewer side effects, and that offer a higher quality of life. Our purpose is rooted in the personal experience of one of Vitalis’ founders, and our culture was born out of the desire to serve patients and work on their behalf.